Pharmather is focused on the research and development of psychedelic pharmaceuticals for FDA approval by finding new uses and drug combinations with panaceAI™ our artificial intelligence drug repurposing platform, novel delivery systems. We are building our product pipeline that targets disorders of the brain and nervous system, which will benefit from the attractive regulatory incentives for expedited approvals, such as the FDA 505(b)(2) regulatory pathway and orphan drug, fast track and breakthrough designations.
